Fungispecificity of fluconazole against Candida albicans
- 1 December 1989
- journal article
- research article
- Published by Springer Nature in Mycopathologia
- Vol. 108 (3) , 173-178
- https://doi.org/10.1007/bf00436222
Abstract
Candida albicans is an opportunistic pathogen of human mucosal surfaces. Colonization of oral and vaginal mucosa by this yeast is antagonized by the resident normal bacterial population. However, antibacterial therapy can alter the normal flora to allow fungal cells to attach, grow and invade host tissues. We studied the antimicrobic activity of fluconazole against clinical isolates of oral and vaginal bacteria and Candida albicans in vitro and in vivo by scanning and transmission electron microscopy; we also compared the bactericidal activity of fluconazole with clotrimazole in vitro by microbiologie assay. Fluconazole lysed fungi but did not change the ultrastructure of bacteria. Clotrimazole, but not fluconazole, was bactericidal against lactobacillus and streptococcus, the principal species of the oral and vaginal cavities. We conclude that Candida albicans, but not oral and vaginal bacteria, is susceptible to fluconazole. These observations help explain the antimycotic specificity of fluconazole and its efficacy against candidiasis in humans.Keywords
This publication has 23 references indexed in Scilit:
- Azole antifungal agents: emphasis on new triazolesAntimicrobial Agents and Chemotherapy, 1988
- Sensitivity testing with ketoconazole in an assay containingCandida albicans, human polymorphonuclear leukocytes and serumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in miceAntimicrobial Agents and Chemotherapy, 1986
- Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Isolates from the Intestinal and Female Genital TractsClinical Infectious Diseases, 1983
- The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitroArchives of Oral Biology, 1980
- Obfuscation of the Activity of Antifungal Antimicrobics by Culture MediaThe Journal of Infectious Diseases, 1972